Cytokinetics, Incorporated
US ˙ NasdaqGS ˙ US23282W6057

Introduktion

Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Robert E Landry. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.

Genomsnittlig handelslönsamhet

Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.

Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.

Uppdateringsfrekvens: Dagligen

Se listan över mest lönsamma insiderhandlare

Se högst rankade insiders
Företag med rapporterade insiderpositioner

SEC-anmälningarna visar att Robert E Landry har rapporterat innehav eller affärer i följande företag:

Värdepapper Titel Senaste rapporterade innehav
Director 0
US:CYTK / Cytokinetics, Incorporated Director 7 333
US:REGN / Regeneron Pharmaceuticals, Inc. EVP Finance CFO 23 693
Hur man tolkar diagrammen

Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Robert E Landry. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.

I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.

Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.

Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.

Insiderköp CYTK / Cytokinetics, Incorporated - Analys av kortsiktig vinst

I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i CYTK / Cytokinetics, Incorporated. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.

Handelsdatum Ticker Insider Rapporterade
aktier		 Rapporterad
pris		 Justerade
aktier		 Justerat
pris		 Kostnadsgrund Dagar till
max		 Pris vid
max		 Max
vinst ($)		 Maximal avkastning (%)
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider

Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.

CYTK / Cytokinetics, Incorporated Insider Trades
Insiderförsäljning - Analys av kortsiktig förlust

I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i CYTK / Cytokinetics, Incorporated. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.

Handelsdatum Ticker Insider Rapporterade
aktier		 Rapporterad
pris		 Justerade
aktier		 Justerat
pris		 Kostnadsgrund Dagar till
min		 Pris vid
min		 Maximal förlust
undvikits ($)		 Maximal förlust
undvikits ($)
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider

Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.

CYTK / Cytokinetics, Incorporated Insider Trades
Insiderhandelshistorik

Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Robert E Landry som avslöjats för Securities Exchange Commission (SEC).

Fildatum Transaktionsdatum Schema Ticker Värdepapper Kode 10b5-1 Aktier Återstående aktier Procentuell förandring Aktie
pris		 Transaktionsvärde Återstående
värde
2025-08-12 3 ZYME Zymeworks Inc.
No securities are beneficially owned 		0
2025-05-14 2025-05-14 4 CYTK CYTOKINETICS INC
Common Stock 		A - Award 7 333 7 333
2024-02-06 2024-02-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −281 23 693 −1,17 956,65 −268 819 22 665 908
2024-02-06 2024-02-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 400 23 974 1,70 378,98 151 592 9 085 667
2024-02-02 2024-01-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −282 23 574 −1,18 953,42 −268 864 22 475 923
2024-02-02 2024-01-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 400 23 856 1,71 378,98 151 592 9 040 947
2024-01-25 2024-01-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −352 23 456 −1,48 951,26 −334 844 22 312 755
2024-01-25 2024-01-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 500 23 808 2,15 378,98 189 490 9 022 756
2024-01-25 2024-01-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −776 23 308 −3,22 948,50 −736 036 22 107 638
2024-01-25 2024-01-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 1 100 24 084 4,79 378,98 416 878 9 127 354
2024-01-18 2024-01-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −354 22 984 −1,52 932,34 −330 048 21 428 903
2024-01-18 2024-01-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 500 23 338 2,19 378,98 189 490 8 844 635
2024-01-17 2024-01-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −568 22 838 −2,43 928,18 −527 206 21 197 775
2024-01-17 2024-01-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 800 23 406 3,54 378,98 303 184 8 870 406
2024-01-08 2024-01-04 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −342 22 606 −1,49 917,05 −313 631 20 730 832
2024-01-08 2024-01-04 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 500 22 948 2,23 378,98 189 490 8 696 833
2024-01-04 2024-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −688 22 448 −2,97 912,30 −627 662 20 479 310
2024-01-04 2024-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 1 100 23 136 4,99 378,98 416 878 8 768 081
2024-01-04 2024-01-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −421 22 036 −1,87 888,34 −373 991 19 575 460
2024-01-04 2024-01-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 650 22 457 2,98 378,98 246 337 8 510 754
2023-12-29 2023-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −612 21 807 −2,73 884,88 −541 547 19 296 578
2023-12-29 2023-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 850 22 419 3,94 378,98 322 133 8 496 353
2023-12-29 2023-12-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −542 21 569 −2,45 872,21 −472 738 18 812 697
2023-12-29 2023-12-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 750 22 111 3,51 378,98 284 235 8 379 627
2023-12-14 2023-12-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −723 21 361 −3,27 871,12 −629 820 18 607 994
2023-12-14 2023-12-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 1 000 22 084 4,74 378,98 378 980 8 369 394
2023-12-14 2023-12-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −6 381 21 084 −23,23 856,71 −5 466 667 18 062 874
2023-12-12 2023-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −2 552 27 465 −8,50 844,09 −2 154 118 23 182 932
2023-12-12 2023-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −669 30 017 −2,18 844,09 −564 696 25 337 050
2023-12-12 2023-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −1 013 30 686 −3,20 843,79 −854 759 25 892 540
2023-08-25 2023-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −223 31 699 −0,70 844,00 −188 212 26 753 956
2023-03-29 2023-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −31 31 922 −0,10 826,36 −25 617 26 379 064
2023-03-29 2023-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −243 31 953 −0,75 825,37 −200 565 26 373 048
2023-03-29 2023-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −157 32 196 −0,49 824,54 −129 453 26 546 890
2023-03-29 2023-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −181 32 353 −0,56 823,60 −149 072 26 645 931
2023-03-29 2023-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −128 32 534 −0,39 822,67 −105 302 26 764 746
2023-03-29 2023-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −142 32 662 −0,43 821,40 −116 639 26 828 567
2023-03-29 2023-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −115 32 804 −0,35 820,85 −94 398 26 927 163
2023-03-29 2023-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −10 32 919 −0,03 818,81 −8 188 26 954 406
2023-03-29 2023-03-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −7 32 929 −0,02 830,01 −5 810 27 331 399
2023-03-29 2023-03-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −4 32 936 −0,01 829,16 −3 317 27 309 214
2023-03-29 2023-03-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −13 32 940 −0,04 825,59 −10 733 27 194 935
2023-03-29 2023-03-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −4 32 953 −0,01 824,30 −3 297 27 163 158
2023-03-29 2023-03-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −18 32 957 −0,05 822,57 −14 806 27 109 439
2023-03-29 2023-03-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −48 32 975 −0,15 821,39 −39 427 27 085 335
2023-03-29 2023-03-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −50 33 023 −0,15 820,46 −41 023 27 094 051
2023-03-29 2023-03-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −39 33 073 −0,12 819,47 −31 959 27 102 331
2023-03-29 2023-03-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −2 204 33 112 −6,24 825,17 −1 818 675 27 323 029
2023-03-29 2023-03-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 3 000 35 316 9,28 378,98 1 136 940 13 384 058
2023-03-29 2023-03-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −589 32 316 −1,79 825,17 −486 025 26 666 194
2023-03-29 2023-03-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 800 32 905 2,49 381,92 305 536 12 567 078
2023-02-07 2023-02-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −28 32 105 −0,09 797,43 −22 328 25 601 490
2023-02-07 2023-02-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −18 32 133 −0,06 796,43 −14 336 25 591 685
2023-02-07 2023-02-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −59 32 151 −0,18 795,41 −46 929 25 573 227
2023-02-07 2023-02-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −99 32 210 −0,31 794,61 −78 666 25 594 388
2023-02-07 2023-02-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −2 32 309 −0,01 793,33 −1 587 25 631 699
2023-02-07 2023-02-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −3 32 311 −0,01 791,00 −2 373 25 558 001
2023-02-07 2023-02-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −10 32 314 −0,03 790,41 −7 904 25 541 309
2023-02-07 2023-02-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −49 32 324 −0,15 789,05 −38 663 25 505 252
2023-02-07 2023-02-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −99 32 373 −0,30 788,62 −78 073 25 529 995
2023-02-07 2023-02-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −58 32 472 −0,18 787,47 −45 673 25 570 726
2023-02-07 2023-02-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −85 32 530 −0,26 786,45 −66 848 25 583 218
2023-02-07 2023-02-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −78 32 615 −0,24 785,88 −61 299 25 631 476
2023-02-07 2023-02-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −113 32 693 −0,34 784,27 −88 623 25 640 139
2023-02-07 2023-02-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −51 32 806 −0,16 783,05 −39 936 25 688 738
2023-02-07 2023-02-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −2 248 32 857 −6,40 774,29 −1 740 604 25 440 847
2023-02-07 2023-02-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 3 000 35 105 9,34 381,92 1 145 760 13 407 302
2023-02-07 2023-02-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −739 32 105 −2,25 764,50 −564 966 24 544 272
2022-12-20 2022-12-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		A - Award 3 853 32 844 13,29
2022-12-12 2022-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −492 28 991 −1,67 753,28 −370 614 21 838 340
2022-12-12 2022-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −2 261 29 483 −7,12 768,54 −1 737 669 22 658 865
2022-12-12 2022-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 3 000 31 744 10,44 381,92 1 145 760 12 123 668
2022-12-02 2022-12-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −12 28 744 −0,04 760,19 −9 122 21 850 901
2022-12-02 2022-12-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −16 28 756 −0,06 759,90 −12 158 21 851 684
2022-12-02 2022-12-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −582 28 772 −1,98 756,50 −440 283 21 766 018
2022-12-02 2022-12-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −1 890 29 354 −6,05 760,35 −1 437 062 22 319 314
2022-12-02 2022-12-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 2 500 31 244 8,70 381,92 954 800 11 932 708
2022-11-02 2022-11-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −19 28 744 −0,07 763,10 −14 499 21 934 546
2022-11-02 2022-11-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −17 28 763 −0,06 762,92 −12 970 21 943 868
2022-11-02 2022-11-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −119 28 780 −0,41 761,36 −90 602 21 911 941
2022-11-02 2022-11-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −13 28 899 −0,04 760,90 −9 892 21 989 249
2022-11-02 2022-11-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −70 28 912 −0,24 759,39 −53 157 21 955 484
2022-11-02 2022-11-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −42 28 982 −0,14 758,20 −31 844 21 974 152
2022-11-02 2022-11-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −81 29 024 −0,28 755,46 −61 192 21 926 471
2022-11-02 2022-11-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −80 29 105 −0,27 754,39 −60 351 21 956 521
2022-11-02 2022-11-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −40 29 185 −0,14 753,23 −30 129 21 983 018
2022-11-02 2022-11-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −1 29 225 0,00 750,00 −750 21 918 750
2022-11-02 2022-10-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −1 518 29 226 −4,94 751,24 −1 140 382 21 955 740
2022-11-02 2022-10-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 2 000 30 744 6,96 381,92 763 840 11 741 748
2022-10-18 2022-10-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −358 28 744 −1,23 739,50 −264 741 21 256 188
2022-10-18 2022-10-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −1 142 29 102 −3,78 743,78 −849 397 21 645 486
2022-10-18 2022-10-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 1 500 30 244 5,22 381,92 572 880 11 550 788
2022-04-11 2022-04-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −68 28 744 −0,24 738,63 −50 227 21 231 181
2022-04-11 2022-04-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −22 28 812 −0,08 737,89 −16 234 21 260 087
2022-04-11 2022-04-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −189 28 834 −0,65 736,61 −139 219 21 239 413
2022-04-11 2022-04-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −149 29 023 −0,51 735,36 −109 569 21 342 353
2022-04-11 2022-04-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −75 29 172 −0,26 734,53 −55 090 21 427 709
2022-04-11 2022-04-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −1 226 29 247 −4,02 733,52 −899 296 21 453 259
2022-04-11 2022-04-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −22 30 473 −0,07 732,56 −16 116 22 323 301
2022-04-11 2022-04-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −37 30 495 −0,12 731,60 −27 069 22 310 142
2022-04-11 2022-04-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −74 30 532 −0,24 729,76 −54 002 22 281 032
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −2 000 0 −100,00
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −6 000 12 800 −31,91
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −1 552 30 606 −4,83 736,21 −1 142 598 22 532 443
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 2 000 32 158 6,63 399,66 799 320 12 852 266
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −4 586 30 158 −13,20 736,21 −3 376 259 22 202 621
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 6 000 34 744 20,87 381,92 2 291 520 13 269 428
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −31 28 744 −0,11 745,27 −23 103 21 422 041
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −56 28 775 −0,19 744,52 −41 693 21 423 563
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −32 28 831 −0,11 743,71 −23 799 21 441 903
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −28 28 863 −0,10 740,98 −20 747 21 386 906
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −29 28 891 −0,10 739,02 −21 432 21 351 027
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −43 28 920 −0,15 735,12 −31 610 21 259 670
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −44 28 963 −0,15 733,38 −32 269 21 240 885
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −16 29 007 −0,06 729,67 −11 675 21 165 538
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −30 29 023 −0,10 728,77 −21 863 21 151 092
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −16 29 053 −0,06 724,33 −11 589 21 043 959
2022-04-11 2022-04-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −1 500 2 000 −42,86
2022-04-11 2022-04-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −1 175 29 069 −3,89 716,09 −841 406 20 816 020
2022-04-11 2022-04-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 1 500 30 244 5,22 399,66 599 490 12 087 317
2022-04-01 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −15 28 744 −0,05 701,98 −10 530 20 177 713
2022-04-01 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −301 28 759 −1,04 695,50 −209 346 20 001 884
2022-04-01 2022-03-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −1 500 3 500 −30,00
2022-04-01 2022-03-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −1 184 29 060 −3,91 700,99 −829 972 20 370 769
2022-04-01 2022-03-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 1 500 30 244 5,22 399,66 599 490 12 087 317
2022-03-30 2022-03-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −147 28 744 −0,51 694,94 −102 156 19 975 355
2022-03-30 2022-03-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −103 28 891 −0,36 693,18 −71 398 20 026 663
2022-03-30 2022-03-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −147 28 994 −0,50 692,38 −101 780 20 074 866
2022-03-30 2022-03-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −226 29 141 −0,77 691,47 −156 272 20 150 127
2022-03-30 2022-03-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −37 29 367 −0,13 690,91 −25 564 20 289 954
2022-03-30 2022-03-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −205 29 404 −0,69 689,33 −141 313 20 269 059
2022-03-30 2022-03-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −542 29 609 −1,80 688,55 −373 194 20 387 277
2022-03-30 2022-03-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −220 30 151 −0,72 687,52 −151 254 20 729 416
2022-03-30 2022-03-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −192 30 371 −0,63 686,67 −131 841 20 854 855
2022-03-30 2022-03-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −176 30 563 −0,57 685,58 −120 662 20 953 382
2022-03-30 2022-03-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −227 30 739 −0,73 684,45 −155 370 21 039 309
2022-03-30 2022-03-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −304 30 966 −0,97 683,29 −207 720 21 158 758
2022-03-30 2022-03-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −103 31 270 −0,33 682,37 −70 284 21 337 710
2022-03-30 2022-03-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −54 31 373 −0,17 681,90 −36 823 21 393 249
2022-03-30 2022-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −1 250 0 −100,00
2022-03-30 2022-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −1 250 0 −100,00
2022-03-30 2022-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −3 500 5 000 −41,18
2022-03-30 2022-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −4 500 8 500 −34,62
2022-03-30 2022-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −4 000 13 000 −23,53
2022-03-30 2022-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −2 785 31 427 −8,14 685,26 −1 908 449 21 535 666
2022-03-30 2022-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 3 500 34 212 11,40 399,66 1 398 810 13 673 168
2022-03-30 2022-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −3 581 30 712 −10,44 685,26 −2 453 916 21 045 705
2022-03-30 2022-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 4 500 34 293 15,10 399,66 1 798 470 13 705 540
2022-03-30 2022-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −3 183 29 793 −9,65 685,26 −2 181 183 20 415 951
2022-03-30 2022-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 4 000 32 976 13,80 399,66 1 598 640 13 179 188
2022-03-30 2022-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −1 134 28 976 −3,77 685,26 −777 085 19 856 094
2022-03-30 2022-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −1 134 28 976 −3,77 685,26 −777 085 19 856 094
2022-03-30 2022-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 1 250 30 110 4,33 555,67 694 588 16 731 224
2022-03-30 2022-03-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 1 250 30 110 4,33 555,67 694 588 16 731 224
2022-03-23 2022-03-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise −400 18 800 −2,08
2022-03-23 2022-03-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −312 28 744 −1,07 691,31 −215 689 19 871 015
2022-03-23 2022-03-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 400 29 056 1,40 381,92 152 768 11 097 068
2022-03-23 2022-03-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −300 28 656 −1,04 693,00 −207 900 19 858 608
2022-03-18 2022-03-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise −365 19 200 −1,87
2022-03-18 2022-03-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −286 28 956 −0,98 682,50 −195 195 19 762 470
2022-03-18 2022-03-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 365 29 242 1,26 381,92 139 401 11 168 105
2022-03-18 2022-03-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −83 28 877 −0,29 686,00 −56 938 19 809 622
2022-03-18 2022-03-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −300 28 960 −1,03 677,00 −203 100 19 605 920
2021-12-14 2021-12-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −116 29 260 −0,39 662,50 −76 850 19 384 750
2021-12-14 2021-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −697 29 376 −2,32 664,34 −463 045 19 515 652
2021-12-14 2021-12-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −1 500 2 500 −37,50
2021-12-14 2021-12-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −1 384 30 073 −4,40 664,34 −919 447 19 978 697
2021-12-14 2021-12-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 1 500 31 457 5,01 555,67 833 505 17 479 711
2021-12-10 2021-12-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −59 29 957 −0,20 672,30 −39 666 20 140 091
2021-12-10 2021-12-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −14 30 016 −0,05 671,42 −9 400 20 153 343
2021-12-10 2021-12-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −58 30 030 −0,19 670,13 −38 868 20 124 004
2021-12-10 2021-12-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −130 30 088 −0,43 669,48 −87 032 20 143 314
2021-12-10 2021-12-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −178 30 218 −0,59 668,21 −118 941 20 191 970
2021-12-10 2021-12-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −7 30 396 −0,02 667,80 −4 675 20 298 449
2021-12-10 2021-12-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −68 30 403 −0,22 666,19 −45 301 20 254 175
2021-12-10 2021-12-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −18 30 471 −0,06 665,44 −11 978 20 276 622
2021-12-10 2021-12-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −15 30 489 −0,05 664,71 −9 971 20 266 343
2021-12-10 2021-12-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −19 30 504 −0,06 663,41 −12 605 20 236 659
2021-12-10 2021-12-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −123 30 523 −0,40 662,06 −81 433 20 208 057
2021-12-10 2021-12-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −25 30 646 −0,08 661,48 −16 537 20 271 716
2021-12-10 2021-12-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −4 30 671 −0,01 659,49 −2 638 20 227 218
2021-12-10 2021-12-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −11 30 675 −0,04 658,52 −7 244 20 200 101
2021-12-10 2021-12-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −50 30 686 −0,16 657,53 −32 876 20 176 966
2021-12-10 2021-12-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −2 30 736 −0,01 656,46 −1 313 20 176 955
2021-12-10 2021-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −4 250 17 000 −20,00
2021-12-10 2021-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −3 469 30 738 −10,14 657,11 −2 279 515 20 198 247
2021-12-10 2021-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 4 250 34 207 14,19 399,66 1 698 555 13 671 170
2021-12-10 2021-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		A - Award 16 958 16 958
2021-12-10 2021-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		A - Award 3 971 29 957 15,28
2021-11-18 2021-11-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −681 25 986 −2,55 645,08 −439 299 16 763 049
2021-11-18 2021-11-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −3 750 21 250 −15,00
2021-11-18 2021-11-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −3 069 26 667 −10,32 651,97 −2 000 896 17 386 084
2021-11-18 2021-11-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 3 750 29 736 14,43 399,66 1 498 725 11 884 290
2021-09-01 2021-08-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise −1 000 4 000 −20,00
2021-09-01 2021-08-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −917 25 986 −3,41 675,03 −619 003 17 541 330
2021-09-01 2021-08-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 1 000 26 903 3,86 555,67 555 670 14 949 190
2021-08-10 2021-08-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −7 25 903 −0,03 619,19 −4 334 16 038 879
2021-08-10 2021-08-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −45 25 910 −0,17 618,89 −27 850 16 035 440
2021-08-10 2021-08-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −1 25 955 0,00 615,73 −616 15 981 272
2021-08-10 2021-08-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −1 25 956 0,00 614,09 −614 15 939 320
2021-08-10 2021-08-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −50 25 957 −0,19 612,31 −30 616 15 893 731
2021-08-10 2021-08-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −433 26 007 −1,64 611,00 −264 563 15 890 277
2021-08-10 2021-08-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −3 000 19 565 −13,29
2021-08-10 2021-08-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −2 463 26 440 −8,52 617,68 −1 521 346 16 331 459
2021-08-10 2021-08-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 3 000 28 903 11,58 381,92 1 145 760 11 038 634
2021-08-10 2021-08-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −36 25 903 −0,14 623,54 −22 447 16 151 557
2021-08-10 2021-08-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −54 25 939 −0,21 621,19 −33 544 16 113 047
2021-08-10 2021-08-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −36 25 993 −0,14 619,70 −22 309 16 107 862
2021-08-10 2021-08-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −58 26 029 −0,22 618,44 −35 870 16 097 375
2021-08-10 2021-08-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −36 26 087 −0,14 617,83 −22 242 16 117 331
2021-08-10 2021-08-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −40 26 123 −0,15 615,42 −24 617 16 076 617
2021-08-10 2021-08-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −66 26 163 −0,25 614,70 −40 570 16 082 396
2021-08-10 2021-08-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −1 26 229 0,00 613,79 −614 16 099 098
2021-08-10 2021-08-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −36 26 230 −0,14 612,97 −22 067 16 078 203
2021-08-10 2021-08-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −1 26 266 0,00 610,85 −611 16 044 586
2021-08-10 2021-08-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −2 000 22 565 −8,14
2021-08-10 2021-08-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −1 636 26 267 −5,86 607,51 −993 886 15 957 465
2021-08-10 2021-08-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 2 000 27 903 7,72 381,92 763 840 10 656 714
2020-12-11 2020-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		A - Award 19 950 19 950
2020-12-11 2020-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		A - Award 1 930 25 903 8,05
2020-08-05 2020-08-04 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −696 23 973 −2,82 654,46 −455 504 15 689 370
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −3 24 669 −0,01 658,00 −1 974 16 232 202
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −388 24 672 −1,55 647,50 −251 230 15 975 120
2020-07-22 2020-07-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −5 000 5 000 −50,00
2020-07-22 2020-07-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −3 500 25 000 −12,28
2020-07-22 2020-07-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −4 611 25 060 −15,54 655,57 −3 022 833 16 428 584
2020-07-22 2020-07-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 5 000 29 671 20,27 555,67 2 778 350 16 487 285
2020-07-22 2020-07-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −2 802 24 671 −10,20 655,57 −1 836 907 16 173 567
2020-07-22 2020-07-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 3 500 27 473 14,60 399,66 1 398 810 10 979 859
2020-07-14 2020-07-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −579 23 973 −2,36 640,50 −370 850 15 354 706
2020-07-13 2020-07-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −3 000 28 500 −9,52
2020-07-13 2020-07-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −2 421 24 552 −8,98 642,46 −1 555 396 15 773 678
2020-07-13 2020-07-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 3 000 26 973 12,51 399,66 1 198 980 10 780 029
2020-07-09 2020-07-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −3 23 973 −0,01 650,41 −1 951 15 592 279
2020-07-09 2020-07-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −94 23 976 −0,39 648,54 −60 963 15 549 395
2020-07-09 2020-07-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −37 24 070 −0,15 646,18 −23 909 15 553 553
2020-07-09 2020-07-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −57 24 107 −0,24 645,99 −36 821 15 572 881
2020-07-09 2020-07-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −104 24 164 −0,43 643,84 −66 959 15 557 750
2020-07-09 2020-07-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −48 24 268 −0,20 642,93 −30 861 15 602 625
2020-07-09 2020-07-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −43 24 316 −0,18 640,32 −27 534 15 570 021
2020-07-09 2020-07-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −80 24 359 −0,33 639,88 −51 190 15 586 837
2020-07-09 2020-07-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −45 24 439 −0,18 638,99 −28 755 15 616 277
2020-07-09 2020-07-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −40 24 484 −0,16 637,40 −25 496 15 606 102
2020-07-09 2020-07-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −585 24 524 −2,33 636,50 −372 352 15 609 526
2020-07-09 2020-07-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −24 25 109 −0,10 634,14 −15 219 15 922 621
2020-07-09 2020-07-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −10 000 10 000 −50,00
2020-07-09 2020-07-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −2 500 31 500 −7,35
2020-07-09 2020-07-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −2 019 25 133 −7,44 640,88 −1 293 937 16 107 237
2020-07-09 2020-07-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 2 500 27 152 10,14 399,66 999 150 10 851 568
2020-07-09 2020-07-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −9 321 24 652 −27,44 640,88 −5 973 642 15 798 974
2020-07-09 2020-07-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 10 000 33 973 41,71 555,67 5 556 700 18 877 777
2020-06-30 2020-06-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −31 23 973 −0,13 616,67 −19 117 14 783 430
2020-06-30 2020-06-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −69 24 004 −0,29 614,64 −42 410 14 753 819
2020-06-30 2020-06-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −153 24 073 −0,63 612,67 −93 739 14 748 805
2020-06-30 2020-06-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −50 24 226 −0,21 611,44 −30 572 14 812 745
2020-06-30 2020-06-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −58 24 276 −0,24 610,73 −35 422 14 826 081
2020-06-30 2020-06-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −39 24 334 −0,16 609,46 −23 769 14 830 600
2020-06-24 2020-06-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −46 24 373 −0,19 635,24 −29 221 15 482 705
2020-06-24 2020-06-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −89 24 419 −0,36 634,63 −56 482 15 497 030
2020-06-24 2020-06-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −82 24 508 −0,33 633,56 −51 952 15 527 288
2020-06-24 2020-06-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −78 24 590 −0,32 631,25 −49 238 15 522 438
2020-06-24 2020-06-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −82 24 668 −0,33 630,84 −51 729 15 561 561
2020-06-24 2020-06-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −39 24 750 −0,16 628,64 −24 517 15 558 840
2020-06-24 2020-06-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −56 24 789 −0,23 626,56 −35 087 15 531 796
2020-06-24 2020-06-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −40 24 845 −0,16 624,65 −24 986 15 519 429
2020-06-24 2020-06-22 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −8 900 20 000 −30,80
2020-06-24 2020-06-22 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −8 388 24 885 −25,21 626,19 −5 252 482 15 582 738
2020-06-24 2020-06-22 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 8 900 33 273 36,52 555,67 4 945 463 18 488 808
2020-06-12 2020-06-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −59 24 373 −0,24 624,56 −36 849 15 222 401
2020-06-12 2020-06-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −16 24 432 −0,07 621,56 −9 945 15 185 954
2020-06-12 2020-06-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −58 24 448 −0,24 620,70 −36 001 15 174 874
2020-06-12 2020-06-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −66 24 506 −0,27 619,73 −40 902 15 187 103
2020-06-12 2020-06-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −31 24 572 −0,13 616,00 −19 096 15 136 352
2020-06-12 2020-06-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −34 24 603 −0,14 614,41 −20 890 15 116 329
2020-06-12 2020-06-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −23 24 637 −0,09 613,53 −14 111 15 115 539
2020-06-12 2020-06-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −177 24 660 −0,71 612,74 −108 455 15 110 168
2020-06-12 2020-06-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −14 24 837 −0,06 611,82 −8 565 15 195 773
2020-06-12 2020-06-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −65 24 851 −0,26 608,91 −39 579 15 132 022
2020-06-12 2020-06-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −445 24 916 −1,75 607,50 −270 338 15 136 470
2020-06-12 2020-06-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −3 500 0 −100,00
2020-06-12 2020-06-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −2 512 25 361 −9,01 610,18 −1 532 772 15 474 775
2020-06-12 2020-06-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 3 500 27 873 14,36 272,70 954 450 7 600 967
2020-06-10 2020-06-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −527 24 373 −2,12 610,25 −321 602 14 873 623
2020-06-10 2020-06-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −681 24 900 −2,66 609,53 −415 090 15 177 297
2020-06-10 2020-06-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −1 511 25 581 −5,58 608,50 −919 444 15 566 038
2020-06-10 2020-06-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −619 27 092 −2,23 607,47 −376 024 16 457 577
2020-06-10 2020-06-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −353 27 711 −1,26 606,79 −214 197 16 814 758
2020-06-10 2020-06-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −289 28 064 −1,02 605,14 −174 885 16 982 649
2020-06-10 2020-06-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −50 28 353 −0,18 604,14 −30 207 17 129 181
2020-06-10 2020-06-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −131 28 403 −0,46 603,68 −79 082 17 146 323
2020-06-10 2020-06-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −110 28 534 −0,38 602,38 −66 262 17 188 311
2020-06-10 2020-06-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −1 500 3 500 −30,00
2020-06-10 2020-06-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −2 250 5 000 −31,03
2020-06-10 2020-06-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −2 250 5 000 −31,03
2020-06-10 2020-06-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −2 500 9 500 −20,83
2020-06-10 2020-06-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −3 500 12 000 −22,58
2020-06-10 2020-06-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −3 500 12 000 −22,58
2020-06-10 2020-06-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −1 086 28 644 −3,65 592,43 −643 379 16 969 565
2020-06-10 2020-06-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 1 500 29 730 5,31 272,70 409 050 8 107 371
2020-06-10 2020-06-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −1 630 28 230 −5,46 592,43 −965 661 16 724 299
2020-06-10 2020-06-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −1 630 28 230 −5,46 592,43 −965 661 16 724 299
2020-06-10 2020-06-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 2 250 29 860 8,15 272,70 613 575 8 142 822
2020-06-10 2020-06-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 2 250 29 860 8,15 272,70 613 575 8 142 822
2020-06-10 2020-06-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −1 811 26 990 −6,29 592,40 −1 072 836 15 988 876
2020-06-10 2020-06-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 2 500 28 801 9,51 272,70 681 750 7 854 033
2020-06-10 2020-06-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −2 536 26 301 −8,79 592,43 −1 502 402 15 581 501
2020-06-10 2020-06-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −2 536 26 301 −8,79 592,43 −1 502 402 15 581 501
2020-06-10 2020-06-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 3 500 28 837 13,81 272,70 954 450 7 863 850
2020-06-10 2020-06-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 3 500 28 837 13,81 272,70 954 450 7 863 850
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −320 24 373 −1,30 573,40 −183 488 13 975 478
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −64 24 693 −0,26 572,42 −36 635 14 134 767
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −114 24 757 −0,46 571,65 −65 168 14 152 339
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −66 24 871 −0,26 569,22 −37 569 14 157 071
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −126 24 937 −0,50 568,11 −71 582 14 166 959
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −114 25 063 −0,45 567,76 −64 725 14 229 769
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −944 25 177 −3,61 566,44 −534 719 14 261 260
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −902 26 121 −3,34 565,52 −510 099 14 771 948
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −340 27 023 −1,24 564,76 −192 018 15 261 509
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −225 27 363 −0,82 563,74 −126 842 15 425 618
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −35 27 588 −0,13 562,71 −19 695 15 524 043
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −12 500 19 000 −39,68
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −9 250 27 623 −25,09 555,82 −5 141 335 15 353 416
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 12 500 36 873 51,29 272,70 3 408 750 10 055 267
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −44 24 373 −0,18 565,77 −24 894 13 789 512
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −66 24 417 −0,27 563,63 −37 200 13 762 154
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −33 24 483 −0,13 562,77 −18 571 13 778 298
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −92 24 516 −0,37 561,96 −51 700 13 777 011
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −232 24 608 −0,93 560,31 −129 992 13 788 108
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −155 24 840 −0,62 559,25 −86 684 13 891 770
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −89 24 995 −0,35 558,63 −49 718 13 962 957
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −33 25 084 −0,13 556,43 −18 362 13 957 490
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −62 25 117 −0,25 553,85 −34 339 13 911 050
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −55 25 179 −0,22 551,38 −30 326 13 883 197
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −3 25 234 −0,01 550,00 −1 650 13 878 700
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −61 25 237 −0,24 548,99 −33 488 13 854 861
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −33 25 298 −0,13 542,25 −17 894 13 717 840
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −33 25 331 −0,13 540,70 −17 843 13 696 472
2020-04-20 2020-04-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −4 000 31 500 −11,27
2020-04-20 2020-04-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −3 009 25 364 −10,61 529,79 −1 594 138 13 437 594
2020-04-20 2020-04-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 4 000 28 373 16,41 272,70 1 090 800 7 737 317
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −2 24 373 −0,01 525,30 −1 051 12 803 137
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −130 24 375 −0,53 520,36 −67 647 12 683 775
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −76 24 505 −0,31 519,58 −39 488 12 732 308
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −287 24 581 −1,15 518,31 −148 755 12 740 578
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −304 24 868 −1,21 517,84 −157 423 12 877 645
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −54 25 172 −0,21 516,89 −27 912 13 011 155
2020-04-16 2020-04-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −3 500 35 500 −8,97
2020-04-16 2020-04-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −2 647 25 226 −9,50 521,45 −1 380 278 13 154 098
2020-04-16 2020-04-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 3 500 27 873 14,36 272,70 954 450 7 600 967
2020-04-13 2020-04-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −46 24 373 −0,19 517,71 −23 815 12 618 146
2020-04-13 2020-04-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −31 24 419 −0,13 512,58 −15 890 12 516 691
2020-04-13 2020-04-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −156 24 450 −0,63 511,59 −79 808 12 508 376
2020-04-13 2020-04-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −143 24 606 −0,58 510,43 −72 991 12 559 641
2020-04-13 2020-04-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −170 24 749 −0,68 509,45 −86 606 12 608 378
2020-04-13 2020-04-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −115 24 919 −0,46 508,54 −58 482 12 672 308
2020-04-13 2020-04-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −30 25 034 −0,12 507,45 −15 224 12 703 503
2020-04-13 2020-04-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −38 25 064 −0,15 506,24 −19 237 12 688 399
2020-04-13 2020-04-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −99 25 102 −0,39 505,60 −50 054 12 691 571
2020-04-13 2020-04-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −3 500 39 000 −8,24
2020-04-13 2020-04-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −2 672 25 201 −9,59 508,25 −1 358 044 12 808 408
2020-04-13 2020-04-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 3 500 27 873 14,36 272,70 954 450 7 600 967
2020-04-08 2020-04-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −2 24 373 −0,01 502,81 −1 006 12 254 988
2020-04-08 2020-04-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −694 24 375 −2,77 497,50 −345 265 12 126 562
2020-04-08 2020-04-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −3 000 42 500 −6,59
2020-04-08 2020-04-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −2 304 25 069 −8,42 499,95 −1 151 885 12 533 247
2020-04-08 2020-04-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 3 000 27 373 12,31 272,70 818 100 7 464 617
2020-04-03 2020-04-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −73 24 373 −0,30 499,37 −36 454 12 171 145
2020-04-03 2020-04-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −62 24 446 −0,25 498,80 −30 926 12 193 665
2020-04-03 2020-04-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −25 24 508 −0,10 497,60 −12 440 12 195 181
2020-04-03 2020-04-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −54 24 533 −0,22 496,33 −26 802 12 176 464
2020-04-03 2020-04-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −2 24 587 −0,01 495,56 −991 12 184 334
2020-04-03 2020-04-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −172 24 589 −0,69 494,42 −85 040 12 157 293
2020-04-03 2020-04-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −99 24 761 −0,40 493,51 −48 857 12 219 801
2020-04-03 2020-04-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −25 24 860 −0,10 492,76 −12 319 12 250 014
2020-04-03 2020-04-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −50 24 885 −0,20 490,66 −24 533 12 210 074
2020-04-03 2020-04-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −121 24 935 −0,48 489,50 −59 230 12 205 682
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −3 000 45 500 −6,19
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −25 25 056 −0,10 497,48 −12 437 12 464 859
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −11 25 081 −0,04 496,28 −5 459 12 447 199
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −69 25 092 −0,27 495,24 −34 172 12 426 562
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −1 500 48 500 −3,00
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −2 000 50 000 −3,85
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −2 500 52 000 −4,59
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −91 25 161 −0,36 494,68 −45 016 12 446 643
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −146 25 252 −0,57 493,54 −72 057 12 462 872
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −109 25 398 −0,43 492,60 −53 693 12 511 055
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −85 25 507 −0,33 491,72 −41 796 12 542 302
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −51 25 592 −0,20 490,11 −24 996 12 542 895
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −128 25 643 −0,50 489,39 −62 642 12 549 428
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −246 25 771 −0,95 488,55 −120 183 12 590 422
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −91 26 017 −0,35 487,29 −44 343 12 677 824
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −78 26 108 −0,30 486,66 −37 959 12 705 719
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −62 26 186 −0,24 485,63 −30 109 12 716 707
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −22 26 248 −0,08 484,96 −10 669 12 729 230
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −139 26 270 −0,53 483,51 −67 208 12 701 808
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −2 317 26 409 −8,07 492,05 −1 140 080 12 994 548
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 3 000 28 726 11,66 272,70 818 100 7 833 580
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −1 162 25 726 −4,32 488,20 −567 288 12 559 433
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 1 500 26 888 5,91 272,70 409 050 7 332 358
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −1 549 25 388 −5,75 488,22 −756 253 12 394 929
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 2 000 26 937 8,02 272,70 545 400 7 345 720
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −1 936 24 937 −7,20 488,22 −945 194 12 174 742
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 2 500 26 873 10,26 272,70 681 750 7 328 267
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −156 24 373 −0,64 493,08 −76 920 12 017 839
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −64 24 529 −0,26 492,61 −31 527 12 083 231
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −87 24 593 −0,35 490,70 −42 691 12 067 785
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −61 24 680 −0,25 489,46 −29 857 12 079 873
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −23 24 741 −0,09 488,77 −11 242 12 092 659
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −23 24 764 −0,09 486,27 −11 184 12 041 990
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −1 24 787 0,00 484,14 −484 12 000 378
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −87 24 788 −0,35 481,91 −41 926 11 945 585
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −75 24 875 −0,30 479,50 −35 962 11 927 562
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −23 24 950 −0,09 478,97 −11 016 11 950 302
2020-02-26 2020-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −34 24 973 −0,14 460,05 −15 642 11 488 829
2020-02-26 2020-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −27 25 007 −0,11 458,35 −12 375 11 461 958
2020-02-26 2020-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −25 25 034 −0,10 457,23 −11 431 11 446 296
2020-02-26 2020-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −10 25 059 −0,04 456,67 −4 567 11 443 694
2020-02-26 2020-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −32 25 069 −0,13 455,37 −14 572 11 415 671
2020-02-26 2020-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −18 25 101 −0,07 454,85 −8 187 11 417 190
2020-02-26 2020-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −44 25 119 −0,17 453,36 −19 948 11 387 950
2020-02-26 2020-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −10 25 163 −0,04 452,04 −4 520 11 374 683
2020-02-26 2020-02-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −1 000 54 500 −1,80
2020-02-26 2020-02-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −17 25 173 −0,07 455,13 −7 737 11 456 987
2020-02-26 2020-02-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −4 25 190 −0,02 454,67 −1 819 11 453 137
2020-02-26 2020-02-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −16 25 194 −0,06 453,60 −7 258 11 427 998
2020-02-26 2020-02-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −35 25 210 −0,14 450,80 −15 778 11 364 668
2020-02-26 2020-02-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −54 25 245 −0,21 449,50 −24 273 11 347 628
2020-02-26 2020-02-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −18 25 299 −0,07 448,54 −8 074 11 347 613
2020-02-26 2020-02-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −37 25 317 −0,15 447,11 −16 543 11 319 484
2020-02-26 2020-02-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −11 25 354 −0,04 445,35 −4 899 11 291 404
2020-02-26 2020-02-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −12 25 365 −0,05 444,03 −5 328 11 262 821
2020-02-26 2020-02-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −10 25 377 −0,04 438,00 −4 380 11 115 126
2020-02-26 2020-02-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −800 25 387 −3,05 447,30 −357 840 11 355 605
2020-02-26 2020-02-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 1 000 26 187 3,97 272,70 272 700 7 141 195
2020-02-26 2020-02-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −1 000 55 500 −1,77
2020-02-26 2020-02-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −786 25 187 −3,03 406,59 −319 580 10 240 782
2020-02-26 2020-02-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 1 000 25 973 4,00 272,70 272 700 7 082 837
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −5 24 973 −0,02 407,66 −2 038 10 180 493
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −4 24 978 −0,02 402,30 −1 609 10 048 649
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −8 24 982 −0,03 401,70 −3 214 10 035 269
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −21 24 990 −0,08 400,54 −8 411 10 009 495
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −22 25 011 −0,09 399,89 −8 798 10 001 649
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −47 25 033 −0,19 398,63 −18 736 9 978 905
2020-02-14 2020-02-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −500 56 500 −0,88
2020-02-14 2020-02-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −393 25 080 −1,54 402,34 −158 120 10 090 687
2020-02-14 2020-02-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 500 25 473 2,00 272,70 136 350 6 946 487
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		A - Award 24 500 24 500
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		A - Award 5 000 24 973 25,03
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		A - Award 2 625 19 973 15,13
2018-12-14 2018-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 20 000 20 000
2018-12-14 2018-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		A - Award 12 500 17 348 257,84
2018-09-11 2018-09-10 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −2 251 4 848 −31,71 395,29 −889 798 1 916 366
2017-12-13 2017-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 23 337 23 337
2017-09-06 2017-09-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 7 099 −1,39 499,69 −49 969 3 547 299
2017-09-06 2017-09-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 7 199 −1,37 498,25 −49 825 3 586 902
2017-09-06 2017-09-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 7 299 −1,35 496,86 −49 686 3 626 581
2017-09-06 2017-09-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −74 7 399 −0,99 496,52 −36 742 3 673 751
2017-09-06 2017-09-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 7 473 −1,32 496,51 −49 651 3 710 419
2017-09-06 2017-09-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −89 7 573 −1,16 501,88 −44 667 3 800 737
2017-09-06 2017-09-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 7 662 −1,29 500,33 −50 033 3 833 528
2017-09-06 2017-09-01 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise X −3 000 57 000 −5,00
2017-09-06 2017-09-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −706 7 762 −8,34 501,29 −353 911 3 891 013
2017-09-06 2017-09-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −1 631 8 468 −16,15 501,29 −817 604 4 244 924
2017-09-06 2017-09-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise X 3 000 10 099 42,26 272,70 818 100 2 753 997
2017-09-01 2017-08-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −127 7 099 −1,76 497,69 −63 207 3 533 101
2017-09-01 2017-08-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 7 226 −1,37 497,42 −49 742 3 594 357
2017-09-01 2017-08-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 7 326 −1,35 489,56 −48 956 3 586 517
2017-09-01 2017-08-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 7 426 −1,33 487,88 −48 788 3 622 997
2017-09-01 2017-08-30 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise X −2 000 60 000 −3,23
2017-09-01 2017-08-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −454 7 526 −5,69 486,91 −221 057 3 664 485
2017-09-01 2017-08-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −1 119 7 980 −12,30 486,91 −544 852 3 885 542
2017-09-01 2017-08-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise X 2 000 9 099 28,17 272,70 545 400 2 481 297
2017-08-24 2017-08-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 7 099 −1,39 478,61 −47 861 3 397 652
2017-08-24 2017-08-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −168 7 199 −2,28 477,10 −80 153 3 434 643
2017-08-24 2017-08-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 7 367 −1,34 475,53 −47 553 3 503 230
2017-08-24 2017-08-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 7 467 −1,32 474,14 −47 414 3 540 403
2017-08-24 2017-08-22 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise X −2 000 62 000 −3,12
2017-08-24 2017-08-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −388 7 567 −4,88 476,10 −184 727 3 602 649
2017-08-24 2017-08-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −1 144 7 955 −12,57 476,10 −544 658 3 787 376
2017-08-24 2017-08-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise X 2 000 9 099 28,17 272,70 545 400 2 481 297
2017-08-09 2017-08-08 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −226 7 099 −3,09 473,57 −107 027 3 361 873
2017-08-09 2017-08-08 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 7 325 −1,35 472,54 −47 254 3 461 356
2017-08-09 2017-08-08 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 7 425 −1,33 471,00 −47 100 3 497 175
2017-08-09 2017-08-08 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 7 525 −1,31 469,91 −46 991 3 536 073
2017-08-09 2017-08-07 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise X −2 000 64 000 −3,03
2017-08-09 2017-08-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −307 7 625 −3,87 466,98 −143 363 3 560 722
2017-08-09 2017-08-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −1 167 7 932 −12,83 466,98 −544 966 3 704 085
2017-08-09 2017-08-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise X 2 000 9 099 28,17 272,70 545 400 2 481 297
2016-12-19 2016-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 24 565 24 565
2015-12-18 2015-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 28 900 28 900
2015-08-06 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −4 000 66 000 −5,71
2015-08-06 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −2 100 7 099 −22,83 593,38 −1 246 098 4 212 405
2015-08-06 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −1 500 9 199 −14,02 592,36 −888 540 5 449 120
2015-08-06 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −400 10 699 −3,60 591,78 −236 712 6 331 454
2015-08-06 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 4 000 11 099 56,35 272,70 1 090 800 3 026 697
2015-04-09 2015-04-08 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise X −10 000 70 000 −12,50
2015-04-09 2015-04-08 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −1 835 7 099 −20,54 449,50 −824 832 3 191 000
2015-04-09 2015-04-08 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −6 066 8 934 −40,44 449,50 −2 726 667 4 015 833
2015-04-09 2015-04-08 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise X 10 000 15 000 200,00 272,70 2 727 000 4 090 500
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 34 000 34 000
2013-09-11 2013-09-09 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 80 000 80 000
2013-09-11 2013-09-09 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		A - Award 5 000 5 000
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)